Predict your next investment

Scioto Biosciences company logo
HEALTHCARE | Biotechnology
sciotobiosciences.com

See what CB Insights has to offer

Founded Year

2017

Stage

Series B | Alive

Total Raised

$35M

Last Raised

$26.5M | 1 yr ago

About Scioto Biosciences

Scioto Biosciences is the developer of the Scioto Platform, a formulation that primes the colony-forming mechanisms of probiotic bacteria by combining beneficial bacteria with polysaccharide microspheres. These natural mechanisms induce 'biofilm' formation, enhance probiotic function, and allow for non-spore forming bacteria to survive passage through the gastrointestinal system.

Scioto Biosciences Headquarter Location

Indiana Center for Biomedical Innovation Noyes Pavilion 5th Floor Suite E504 1800 N. Capitol Ave.

Indianapolis, Indiana, 46202,

United States

(866) 672-4686

Latest Scioto Biosciences News

Autism Pipeline Review, H2 2020 Featuring 40+ Companies - Therapeutics Development, Drug Profiles, Dormant Projects, Development Milestones - ResearchAndMarkets.com

Dec 21, 2020

Autism - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Autism (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 2, 6, 4, 1, 21, 4 and 1 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 2 molecules, respectively. Autism (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Reasons to Buy Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Find and recognize significant and varied types of therapeutics under development for Autism (Central Nervous System). Classify potential new clients or partners in the target demographic. Develop tactical initiatives by understanding the focus areas of leading companies. Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. Formulate corrective measures for pipeline projects by understanding Autism (Central Nervous System) pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline. Key Topics Covered: Autism - Drug Profiles ChunLab Inc Scioto Biosciences Inc Therapix Biosciences Ltd

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Scioto Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Scioto Biosciences is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

M

Microbiome

274 items

Scioto Biosciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Scioto Biosciences Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.